1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derivied relaxing factor produceed and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA1987; 84: 9265-9.
2. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
3. Nussler AK, Billiar TR. Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukoc Biol (USA) 1993;54(2):171-8.
4. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: A physiologic messenger. Ann Intern Med 1994; 120: 227-37.
5. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: Physology, Pathophysology, and Pharmacology. Pharmaco Reviews 1991;
43('9: 109-37.
6. Star RA. Nitric oxide. Am J Med Sci (USA). 1993;306(5):348-
58.
7. Tayeh MA, Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate: Tetrahydrobiopterin is
required as a cofactor. J Biol Chem. 1989; 264:19654-8.
8. Moncado S. The L-arginine: Nitric oxide pathway. Acta
Physiol Scand 1992; 145(3): 201-27.
9. Ignarro LJ. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension
(USA) 1990;16(5):477-83.
10. Andersson KE, Persson K. Nitric oxide synthase and nitric oxide-mediated effects in lower urinary Tract smooth muscle.
World J Urol (Germany) 1994;12(5):274-80.
11. Knowles RG, Moncada S. Nitric oxide senthases in mammals.
Bichem J 1994; 298: 249-58.
12. Marletta MA. Approaches toward selective inhibition of nitrik
oxide synthase. J Med Chem 1994; 37: 1899-907.
13. Cendan JC, Topping DL, Pruitt J, Snowdy J, Copeland EM, Lind DS. Inflammatory mediators stimulate arginine transport and arginine-derived nitric oxide production in a murine breast
cancer line. J Surg Res.USA 1996; 60(2): 248-88.
14. Dawson VL. Nitric oxide: role neurotoxicity. Clin Exp
Pharmacol Physiol (Australia) 1995;22(4):305-8.
15. Bachmann S, Mundel P. Nitric oxide in the kidney: Synthesis, localization and fonction. Am J Kid Diseas 1994; 24(1): 112¬29.
16. Hevel JM, White KA, Marletta MA,: Pürification of the
inducible murine macrophage nitric oxide synthase. Identification as aflavoprotein. J Biol Chem 1991; 266: 22789¬91.
17. Geller DA, Lowenstein CS, Shapiro RA, Nussler AK, Disilvio N, Wang S, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 3491- 5.
18. Snyder SH. Nitric oxide: First in a new class of neurotransmitters. Science 1992;257: 494-6.
19. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann
Neurol 1992;32:297-311.
20. Tottrup A, Glavihd EB, Svane D. Involvement of the L-arginine-nitric oxide pathway in internal analspinchter relaxation. Gastroentrology 1992;102:409-15.
21. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovasculer system. Prog Cardiovasc Dis (U S A).
1995;38(2):87-104.
22. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hipertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992;10:1025-31.
23. Sogni P, Moreau R, Ohsuga M, Cailmail SiOberti F, Hadengu A,et al. Evidence for normal nitric oxide-mediated vasodilator tone in consciosis. Hepatology 1992;16:980-3.
24. McCall TB, Feelisch M, Palmer RMJ, Moncada P.
Identification of N- iminoethyl-L- ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. B J Pharmocol 1991; 102: 234-8.
25. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther (U S A). 1994;8(4):601-10.
26. Varela AF, Runge A, Ignarro LJ, Chaudhuri G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults. Am J Obstet Gynecol
1992;167:1599-604.
27. De Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992;85:2284-90.
28. Radomski MW, Palmer RMS, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-8.
29. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J
Pharmacol 1990;101:325-8.
30. Kubes P, Suzuki M, Granger DM. Nitric oxide: An endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651- 5.
31. Wolfe TA, Dasta JF. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother (USA)
1995;29(1):36-46.
32. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C,
Baranowski RL, et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving
interleukin-2 therapy. J Clin Invest 1992;89:867-77.
33. Hotchkiss RS, Karl IE, Parker JL, Adams HR. Inhibition of
NO synthesis in septic shock. Lancet 1992;339:434-5.
34. Luscher TF, Diederich D, Siebenmann R, et al. Difference between endothelium- dependent relaxation in arterial and in venous coronary bypass grafts. N Eng J Med 1988; 319: 462-7.
35. Cox DA, Vita JA, Treasure CB, et al. Atherosclerosis impairs flow mediated dilatoin of coronary arteries in human.
Circulation 1989; 80: 458-65.
Journal ofTurgut Özal Medical Center 4(4):1997
459
Nitrik oksit'in etkileri ve patolojik rolleri
Y. Türköz ve ark.
36. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfuntion in child ren and adulys at risk of Atherosclerosis. Lancet 1992; 340:1111-5.
37. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfuntion in coronary microcirculation of hypercholesterolaemic patients by L- arginine. Lancet 1991;
338: 1546-50.
38. Creager HA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium- dependent vasodilation in hypercholesterolaemic humans. J Clin Invest 1992; 90: 1248- 53.
39. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium- dependent vascular relaxation in patients with essential hypertension . N Eng J Med 1990;323: 22-7.
40. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of
endothelium derived nitric oxide in the abnormal endothelium dependent vascular relaxation of patients with essential
hypertension. Circulation 1993;87:1468-74.
41. Balis C, Mitruka B, Deng A. Chronic blockade of nitrik oxide synthesis in the rat produces systemic hypertansion and glomerular damage. J Clin Invest 1992; 90: 278-81.
42. Yukimura T, Yamashita Y, Miura K, Okumura M, Yamanaka S, Yamamota K. Renal effects of the nitric oxide synthase inhibitor; L-NG- niyroarginine, in dogs.Am J Hypertens 1992;
5: 484-7.
43.
MM. Diabetes mellitus increase nitric oxide synthase in penises but not in major pelvic ganglia of rats. B J Urol 1995;
76: 196-202.
44. Vallence P, Leone A, Calver A, Colier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
45. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes (USA) 1992;41(8):899-903.
46. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric
oxide in persistent pulmonary hypertension of the newborn.
Lancet 1992;340:818-9.
47. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
48. Pepka-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D,
Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet
1991; 338: 1173-4.
49. Gustafsson LE, Leone AM, Persson MG; Wiklund NP,
Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res
Commun 1991; 181: 852-7.
50. Pizcueta P, Pique JM, Fernandez M, Bosch J,Whittle BJ,et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909-15.
51. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med
1992;176:261-4.
52. Lynch DR, Dawson TM. Secondary mechanism in neuronal
trauma . Curr Opin Neurol (USA) 1994;7(6):510-6.
53. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in
brain. Circ Res 1993;72:476-80.
54. Paakkari I, Lindsberg P. Nitric oxide in the central nervous
system. Ann Med (England) 1995;27(3):369-77.
55. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol (USA) 1995;57:683-706.
56. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends
Pharmacol Sci (England) 1994;15(5):149-53.
57. Rand MJ, Li CG. Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission.Annu Rev Physiol (USA) 1995;57:659-82.
58. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide : a physiologic mediator of penile erection. Science 1992;257:401-3.
59. Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ. Nitric
oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 1992;147:1650-5.
60. Trigo-Rocha F, Aronson WJ, Hohenfellner M, Ignarro LJ, Rajfer J, Lue TF. Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol
1993;264:H419-22.
61. Burnett AL, Tillman SL, Chang TS; Epstein JL, Lowenstein CJ, Bredt DS, et al. :Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol 1993; 150:73-8.
62. Iselin CE, Alm P, Schaad NC, Larsson B, Grabber P, Andersson KE. Nitric oxide inhibits contraction of isolated pig ureteral smooth muscle. J Urol 1996; 155: 763-7.
63.
nitric oxide mediates relaxation of canine corpus cavernosum. J Urol 1996; 155: 1122-7.
64. Toda N, Kitamura Y, Okamura T. Role of nitroxidergic nerve in dog retinal arterioles invivo and arteries invitro. Am J Physiol 1994; 266: H1985-89.
65. Burnett AL, Takeda M, Maguire MP, Lepor H, Chamness SL, Chang TSK, Ricker DD. Characterization and localization of nitric oxide synthase in the human protate. Urology 1995; 45:
435-40.
66. Munoz-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrofage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.Eur J Immunol 1992;22:301-7.
67. Liew FY, Li Y, Millott S. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is.mediated by nitric oxide from L-arginine. Immunology 1990;71:556-9.
68. Green SJ, Meltzer MS, Hibbs JB Jr, Nacy CA. Activated
macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J
Immunol 1990;144:278-83.
460
Turgut Özal Tıp Merkezi Dergisi 4(4): 1997
Türköz
Y
, et al.
Nitric oxide : actions and pathological roles
69. Lin JY, Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide
from L-arginine. J Immunol 1992;148:3999-4005.
70. Zhang J, Snyder SH. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehidrogenase.
Proc Natl Acad Sci USA 1992;89:9382-5.
71. Dimmeler S, Brune B. Characterization of a nitric-oxide-catalaysed ADP-ribosylation of glyseraldehyde-3-phosphate dehidrogenase. Eur J Biochem 1992;210:305-10.
72. Taylor-Robinson AW, Severn A, Phillips RS. Kinetics of nitric oxide production during infection and reinfection of mice with Plasmodium chabaudi. Parasite-Immunology 1996;18-8:425-
30.
73. Lepoivre M, Feischi F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide.
Biochem Biophys Res Commun 1991;179:442-8.
74. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J
Exp Med 1991;174:761-8.
75. Croen KD. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin
Invest 1993;91:2446-52.
76. Karupia G, Xie Q, Buller RML, Nathan C, Duarte C,
MacMicking JD. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science 1993;261:1445-
8.
Thank you for copying data from http://www.arastirmax.com
